Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson purchased 199 shares of Dr. Martens stock in a transaction dated Wednesday, December 11th. The stock was bought at an average price of GBX 76 ($0.96) per share, with a total value of £151.24 ($190.89).
Kenny Wilson also recently made the following trade(s):
- On Thursday, September 26th, Kenny Wilson acquired 30,000 shares of Dr. Martens stock. The stock was bought at an average price of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,825.44).
Dr. Martens Stock Down 0.6 %
Dr. Martens stock opened at GBX 76.55 ($0.97) on Friday. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.62) and a fifty-two week high of GBX 100 ($1.26). The firm has a market capitalization of £736.20 million, a PE ratio of 1,093.57, a P/E/G ratio of 6.40 and a beta of 0.11. The company’s 50-day moving average is GBX 59.81 and its 200-day moving average is GBX 67.37. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than Dr. Martens
- How to Use Stock Screeners to Find Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Investing in Travel Stocks Benefits
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Airline Stocks – Top Airline Stocks to Buy Now
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.